Associate Director, Immunogenicity Assessment, Non-clinical and Clinical Assay Sciences

.

Are you an experienced leader passionate about developing people and building high-performing teams? Join Novo Nordisk and lead a critical immunogenicity assessment department that plays a pivotal role in evaluating the safety of innovative medicines. This is a co-leadership role where you have joint responsibility for the Immunogenicity Assessment area. You will combine strategic and people leadership, stakeholder collaboration, and scientific expertise to help bring life-changing treatments to patients worldwide.

Your new role As Associate Director, you will work in a close co-leadership with an experienced existing leader. Your own department consists of 17 scientists and technicians, while the area has a total of 38 employees. The area is responsible for driving the immunogenicity strategy across the project portfolio, including the design, execution, interpretation, and reporting of state-of-the-art immunogenicity studies conducted both in-house and through external CRO partnerships. You will ensure fit-for-purpose immunogenicity assessments that support safety evaluations, from early non-clinical development through clinical development and product lifecycle management.

Beyond leading the department, you will facilitate shaping of the scientific strategy, drive cross-functional collaboration, and ensure delivery of high-quality data and regulatory documentation that support drug development and registration milestones.

Your key responsibility

• Co-lead a high-performing area characterized by a high level of accountability, empowerment, and scientific expertise
• Coach and develop a team of scientists and technicians, fostering a culture of psychological safety, scientific excellence, collaboration, and continuous improvement to deliver high-quality immunogenicity work in compliance with GLP/GCP standards
• Ensure timely and strategically value-driven delivery of high-quality immunogenicity data, and regulatory documentation supporting clinical trial applications and global market registrations.
• Build and maintain strong relationships with key internal stakeholders across Clinical Development, Regulatory Affairs, Research, and CMC
• Contribute actively to the NCAS leadership team through strategic initiatives, resource allocation, budget management, and organisational development.
• Represent Novo Nordisk externally through scientific collaborations, industry forums, conferences, and interactions with health authorities

Your new department The Immunogenicity Assessment department is part of Non-clinical and Clinical Assay Sciences (NCAS) within Research and Development at Novo Nordisk. NCAS delivers non-clinical and clinical bioanalysis, including biomarker and immunogenicity assessments, supporting projects across the entire Novo Nordisk portfolio.

NCAS consists of eight departments organised in a collaborative co-leadership structure, where leaders work closely together to achieve shared goals and ensure strong scientific and organisational outcomes. In this role, you will work in very close partnership with the other leader of Immunogenicity Assessment

The department is responsible for assessing the immunogenic potential of Novo Nordisk compounds and generating critical scientific evidence that informs project decisions, safety evaluations, and regulatory submissions throughout the product lifecycle.

Your skills & qualifications
We are looking for an experienced people leader who thrives in a complex, fast-paced environment and is passionate about leadership and strong collaboration. You are ready to enter a close collaboration as co-leader with your peer manager of Immunogenicity Assessment.

You will bring:

• Leadership experience, with a proven track record of developing people, building high-performing teams, and delivering results through others.
• Demonstrated ability to influence strategic decisions and navigate complex stakeholder environments across global matrix organisations.
• Strong communication, coaching, and collaboration skills, with the ability to build trust and engagement across organisational boundaries.
• A proactive, resilient, risk-willing, and results-oriented mindset, thriving in a dynamic and evolving environment.
• Experience with bioanalysis and/or immunogenicity assessments, combined with a strong understanding of relevant regulatory expectations and GxP principles would be a plus
• Background within immunology, biology, biochemistry, pharmacology, or another relevant life science discipline. PhD preferred.

Working at Novo Nordisk
Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with determination, constant curiosity and a commitment to finding better ways forward. For over 100 years, this dedication has driven us to build a company focused on lasting change for long-term health. One where diverse thinking, shared purpose and mutual respect come together to create extraordinary results. When you join us, you're not just starting a job – you're becoming part of a story that spans generations.

What we offer

There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.

Salary: For this role, the Annual Base Salary ranges from 847,000 to 1,245,100 DKK (DK) , corresponding to the level of the position. The placement within the salary range will be assessed during the recruitment process based on the candidate’s skills, competencies, knowledge, and relevant experience.

Incentives and Benefits: The salary package may include short-term and/or long-term incentives as well as other employee benefits based on position level, location, functional area and relevant market benchmarks.

Learn more about our Reward Philosophy here

Contact

For further information about the position, please contact Sif Groth Rønn by phone: Vis telefonnummer

Deadline

28th August 2026

Applications are reviewed on an ongoing basis

.